PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,893,541 | -82.2% | 307,610 | -67.6% | 0.00% | -75.0% |
| Q2 2023 | $38,653,429 | -17.3% | 950,416 | -1.5% | 0.01% | -20.0% |
| Q1 2023 | $46,759,437 | +25.1% | 965,306 | -1.5% | 0.01% | +11.1% |
| Q4 2022 | $37,388,126 | -26.6% | 979,516 | -3.5% | 0.01% | -25.0% |
| Q3 2022 | $50,967,000 | +25.0% | 1,015,294 | -0.3% | 0.01% | +33.3% |
| Q2 2022 | $40,777,000 | +2.5% | 1,017,870 | -4.6% | 0.01% | +12.5% |
| Q1 2022 | $39,787,000 | -10.5% | 1,066,395 | -4.5% | 0.01% | 0.0% |
| Q4 2021 | $44,468,000 | -2.4% | 1,116,476 | -8.8% | 0.01% | -11.1% |
| Q3 2021 | $45,553,000 | -11.3% | 1,224,227 | +0.8% | 0.01% | -10.0% |
| Q2 2021 | $51,339,000 | +34.7% | 1,214,597 | +50.9% | 0.01% | +25.0% |
| Q1 2021 | $38,125,000 | -19.4% | 805,161 | +3.8% | 0.01% | -20.0% |
| Q4 2020 | $47,327,000 | +36.1% | 775,472 | +4.2% | 0.01% | +11.1% |
| Q3 2020 | $34,786,000 | -7.9% | 744,087 | -0.0% | 0.01% | -10.0% |
| Q2 2020 | $37,770,000 | +144.2% | 744,378 | +114.7% | 0.01% | +100.0% |
| Q1 2020 | $15,464,000 | +0.9% | 346,647 | +8.6% | 0.01% | +25.0% |
| Q4 2019 | $15,327,000 | +47.7% | 319,120 | +4.0% | 0.00% | +33.3% |
| Q3 2019 | $10,375,000 | -25.5% | 306,757 | -0.8% | 0.00% | -25.0% |
| Q2 2019 | $13,918,000 | +22.6% | 309,296 | +2.5% | 0.00% | +33.3% |
| Q1 2019 | $11,356,000 | +28.3% | 301,704 | +16.9% | 0.00% | 0.0% |
| Q4 2018 | $8,854,000 | -2.4% | 258,004 | +33.7% | 0.00% | +50.0% |
| Q3 2018 | $9,068,000 | +44.6% | 192,943 | +3.8% | 0.00% | 0.0% |
| Q2 2018 | $6,269,000 | +29.3% | 185,830 | +3.7% | 0.00% | +100.0% |
| Q1 2018 | $4,850,000 | +62.3% | 179,230 | +0.0% | 0.00% | 0.0% |
| Q4 2017 | $2,989,000 | -12.9% | 179,170 | +4.5% | 0.00% | 0.0% |
| Q3 2017 | $3,431,000 | +15.5% | 171,477 | +5.8% | 0.00% | 0.0% |
| Q2 2017 | $2,970,000 | +65.7% | 162,008 | -11.0% | 0.00% | – |
| Q1 2017 | $1,792,000 | +1.5% | 182,048 | +12.4% | 0.00% | -100.0% |
| Q4 2016 | $1,766,000 | -24.6% | 161,925 | -3.1% | 0.00% | 0.0% |
| Q3 2016 | $2,342,000 | +122.4% | 167,144 | +11.4% | 0.00% | – |
| Q2 2016 | $1,053,000 | +12.7% | 150,068 | +3.5% | 0.00% | – |
| Q1 2016 | $934,000 | -80.8% | 145,024 | -3.7% | 0.00% | -100.0% |
| Q4 2015 | $4,877,000 | +26.4% | 150,521 | +4.2% | 0.00% | 0.0% |
| Q3 2015 | $3,857,000 | -50.5% | 144,466 | -10.8% | 0.00% | -50.0% |
| Q2 2015 | $7,791,000 | -7.8% | 161,875 | +16.6% | 0.00% | 0.0% |
| Q1 2015 | $8,450,000 | +10.1% | 138,866 | -6.3% | 0.00% | 0.0% |
| Q4 2014 | $7,673,000 | +22.6% | 148,215 | +4.2% | 0.00% | 0.0% |
| Q3 2014 | $6,257,000 | -14.7% | 142,177 | -49.4% | 0.00% | +100.0% |
| Q2 2014 | $7,338,000 | +428.3% | 280,762 | +428.5% | 0.00% | – |
| Q1 2014 | $1,389,000 | +100.4% | 53,120 | +29.9% | 0.00% | – |
| Q4 2013 | $693,000 | -36.8% | 40,880 | -20.0% | 0.00% | – |
| Q3 2013 | $1,096,000 | – | 51,114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AXON CAPITAL LP | 216,200 | $9,729,000 | 20.31% |
| GREAT POINT PARTNERS LLC | 1,974,385 | $88,847,000,000 | 9.86% |
| RTW INVESTMENTS, LP | 3,137,361 | $141,181,000 | 7.54% |
| Asymmetry Capital Management, L.P. | 280,542 | $12,624,000 | 6.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 259,000 | $11,642,000 | 4.32% |
| Boxer Capital, LLC | 1,000,000 | $45,000,000 | 3.87% |
| Opaleye Management Inc. | 226,388 | $10,187,000 | 3.10% |
| SECTORAL ASSET MANAGEMENT INC | 450,638 | $20,279,000 | 2.42% |
| SCOPIA CAPITAL MANAGEMENT LP | 983,005 | $44,235,000 | 1.96% |
| Chubb Ltd | 8,180 | $368,000 | 1.82% |